Baris Esen

Disclosure information not submitted.

Presentation(s):

• MP11-07: Radioligand Therapy with ¹⁷⁷Lu-PSMA-I&T in Patients with Metastatic Castration-Resistant Prostate Cancer: Oncological Outcomes and Toxicity Profile

  Friday, April 28, 2023
  9:30 AM – 11:30 AM CST